Subtilisin kexin isozyme-1 (SKI-1) represents the first mammalian member of secretory subtilisin-like processing enzymes that cleaves after non-basic residues. It is synthesized as an inactive precursor that undergoes three sequential autocatalytic processing steps of its N-terminal prosegment and an ectodomain shedding at a site near the transmembrane domain. The various cellular functions of SKI-1 emphasize the need to understand the sites of its activation and shedding.
INTRODUCTION
Several secretory proteins are synthesized as inactive precursors, which when converted to their mature forms by proteolytic enzymes generate a large diversity of bioactive proteins and peptides. The 9-membered family of the proprotein convertases (PCs) participate actively in the generation of such molecular diversity (1) (2) (3) . There are seven basic amino acid specific kexin-like mammalian proprotein convertases that cleave various precursors at the general consensus motif (K/R)-(X) n -(K/R)↓, where n=0, 2, 4 or 6 and X is any amino acid. The eighth member is the pyrolysinlike subtilisin kexin isozyme-1 (SKI-1) (4), also known as site-1 protease (S1P) (5) . It cleaves substrates at the consensus motif (R/K)-X-(hydrophobic)-X↓, where X is variable (6) . The last member PCSK9 cleaves the sequence VFAQ 152 ↓ within its prosegment (7) .
SKI-1 represents the first mammalian member of secretory subtilisin-like processing enzymes that cleaves after nonbasic residues (2;3). The ubiquitously expressed convertase SKI-1 (4) regulates the synthesis of cholesterol and fatty acids and their metabolism, through the processing of the membrane-bound transcription factors sterol regulatory element binding proteins (SREBPs) (8;9) . It also regulates endoplasmic reticulum (ER)-stress response through cleavage of ATF6 (10) , and is involved in the processing of pro-brain derived neurotrophic factor (4) . Recently, SKI-1 was reported to process Luman, a basic leucine zipper transcription factor, as well as other CREB-like bZIP factors (11) . The enzyme also plays a major role in the processing of surface glycoproteins of infectious viruses such as Lassa (12) , lymphocytic choriomeningitis (LCMV) (13) and Crimean Congo hemorrhagic fever (CCHV) viruses (14) .
SKI-1 is synthesized as an inactive precursor of 1,052 amino acids (aa) that is activated following three sequential autocatalytic processing events within its prosegment (sites B/B' and C, Fig. 1A ) (15) . The membrane-bound SKI-1 is rendered soluble via an autocatalytic ectodomain shedding event at a KHQKLL 953 ↓ site near the transmembrane domain ( Fig. 1A) (15) , similar to many cell-surface proteins, e.g., growth factors, cytokine, growth factor receptors, and β-amyloid precursor proteins (16) . Shedding of SKI-1 releases a soluble protein sSKI-1 (aa 188-953), leaving behind a membranebound stub (St-1; aa 954-1052) (Fig.  1A) . The biological importance of the shedding and the role, if any, of the membrane-bound stub St-1 is unknown.
In the present study, we have identified a new mechanism generating a smaller membrane-bound C-terminal fragment (CTF), denoted as St-2 (Fig. 1A ).
Microsequencing and mass spectrometric data revealed that St-2 starts at Met 990 . Site directed mutagenesis and in vitro transcription/translation indicated a unique alternate translation event starting at Met 990 . Immunocytochemistry performed on endogenous and overexpressed SKI-1, and various constructs including those coding for St-1 and St-2 revealed that SKI-1 can sort to endosome/lysosomes, but not to the cell surface. These stumps seem to interfere with the ability of SKI-1 to process proATF6 into its nuclear form in response to cellular stress.
EXPERIMENTAL PROCEDURES
Cell culture -Human embryonic kidney (HEK293) cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% heat inactivated fetal bovine serum (FBS), chinese hamster ovary CHOK1, human hepatocytes (HuH7), M19 cells lacking site-2 protease S2P (17) , and Neuro 2A were grown in the Ham's DMEM:F12 media containing 10% FBS. SRD-12B cells lacking SKI-1/S1P expression (18) were cultured in 1:1 mixture of Ham's F-12 medium and DMEM containing 100 µg/ml streptomycin sulfate supplemented with 5% FBS, 5 µg/ml cholesterol, 1 mM sodium mevalonate, and 20 µM sodium oleate.
Recombinant stump-1 (rSt-1) and its mutants -All oligonucleotides used in the various constructions are listed in Table I . To obtain enough protein for sequencing and mass spectrometric analysis, the Cterminal fragment of human SKI-1 (aa 954-1052) rSt-1 was amplified by PCR using the pIRES-SKI-1-V5 cDNA (4) as template using primers S1/AS1 with Xho1/BamH1 restriction sites. The PCR product obtained was digested with Xho1/BamH1 and cloned into the vector pIRES-EGFP (Invitrogen) to which the FLAG (DYKDDDK) epitope was fused in frame just after the signal peptide cleavage site and the V5 (GKPIPNPLLGLDST) epitope placed at the C terminus of the molecule. All other point mutants of SKI-1 and rSt-1 were generated with the QuikChange II site-directed mutagenesis kit (Stratagene) using the above constructs as template and appropriate pairs of oligonucleotides (Table  I) : I985A (S2/AS2), M990A (S3/AS3), M990L (S4/AS4), M990I (S5/AS5), I989L (S6/AS6), Y994A (S7/AS7), N995A (S8/AS8), Y/N994/995A (S9/AS9). All recombinant cDNAs constructs were confirmed by DNA sequencing.
Recombinant stump-2 (rSt-2) and cytosolic tail (rCT) -The smaller C-terminal fragments starting at Met 990 (aa 990-1052) and rCT (aa 1023-1052) were PCR amplified using SKI-1-V5 as template, and the oligonucleotide pairs S10/AS10 and S11/AS11, respectively. The PCR products obtained were digested with either Xho1/BamH1 or Pst1/Age1 and cloned into pIRES-EGFP and their DNA sequenced in both directions. The other two constructs rΔCT, rBTMD were previously described (15) .
Biosynthetic analysis -HEK293 cells (2-4 x 10 5 ) in 60 mm dishes were transiently transfected with 1.2 μg SKI-1-V5 cDNA using Effectene (Qiagen). Two days post transfection the cells were washed and pulse-labeled with 400 μCi/ml [ 3 H]Arg (Amersham Bioscience) for 4h (19) . The cell lysates were immunoprecipitated with mAb:V5 (1:500) in buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 6.8), 0.5% Nonidet P-40, 0.5% sodium deoxycholate and a mixture of protease inhibitors (Roche Molecular Biochemicals). The immunoprecipitates were resolved by SDS-PAGE on 8% Tricine gels, dried and autoradiographed as described (20) .
Western blot analysis -To detect the presence of St-2, HEK293 cells were transiently transfected with either the wildtype or active site mutant H249A cDNA constructs, as mentioned previously.
CHOK1 and SRD-12B cells were transiently transfected with 4 μg of SKI-1 or SKI-1 mutant cDNAs using Lipofectamine 2000 (Invitrogen). Two days post-transfection cells were washed twice with phosphate buffered saline (PBS), lysed in sodium dodecyl sulfate (SDS) buffer (10 mM Tris-HCl (pH 7.5), 100 mM NaCl and 1% SDS) containing a mixture of protease inhibitors. The samples were incubated on ice for 30 min, and the lysates were run on 8% TrisTricine gel. Following SDS-PAGE, proteins were transferred to nitrocellulose membrane (Amersham) that was subsequently analyzed by immunoblotting using mAb:V5 (1:5000) and the protein bands were visualized by an ECL chemiluminescence kit (Amersham biosciences), used according to the manufacturer's instructions.
Effect of various classes of protease inhibitors on the generation of rSt-2 -4 x 10
5 CHOK1 cells were transiently transfected with 4 μg of SKI-1-V5 cDNA and rSt-1. Twenty four hours posttransfection, the cells were washed and incubated for 6h in medium containing different protease inhibitors (21) . Western blot analyses were carried out following 8% SDS-PAGE using mAb:V5 (1:5000). Inhibitors were tested at various concentrations (Table II) In vitro transcription/translation -rSt-1 was excised from pIRES-rSt-1-V5 using HindIII/BamH1 and subcloned into the pCDNA3 vector. The mutants M990A and I989L were obtained using the Quikclone mutagenesis kit (Stratagene). Recombinant pCDNA3-rSt1-V5 (WT), M990A and I989L cDNAs were transcribed/translated using a TNT coupled reticulocyte system according to manufacturers protocol with wheat germ extract (Promega) containing [ 35 S]Met in the presence or absence of canine pancreatic microsomal membranes. The reaction was carried out at 30°C for 90 min, samples separated on SDS-PAGE and Western blots analyzed using mAb:V5 (1:5000).
Production of hSKI-CT antibody -Human SKI-1 polyclonal antibody was generated by immunizing two rabbits with a peptide containing an N-terminal Cys linked to the segment aa 1036-1051 of SKI-1 (C-RPQLMQQVHPPKTPSV), which was conjugated to keyhole limphet hemocyanin using a standard KLH conjugation kit protocol (Sigma-Aldrich). The two rabbits bleeds were analyzed and the best one obtained at the second bleed (R2-02) called Ab:CT was used for Western blot analysis (1:1000) and sub-cellular localization (1:500) studies.
Immunocytochemistry
and confocal microscopy -To detect endogenous SKI-1, Human hepatocytes (HuH7) cells were plated, and 24h later the cells were fixed with 4% formaldehyde for 30 min at room temperature and washed with PBS containing 0.1% triton to permeabilize them. Immunostaining was done as described previously (22) . Cells were incubated with primary Ab:CT antibody (1:500) at 4ºC overnight along with markers for different compartments cis/medial Golgi (Golga1) (1:500), early endosomal marker (EEA1) (1:500) and late endosomal marker (cation independent -mannose-6-phosphate receptor; CI-MPR) (1:500) (Abcam) at 4ºC overnight. The cells were washed and incubated with a mixture of two secondary fluorescently labeled antibodies, i.e., anti-rabbit (Alexa Fluor 555) or anti-mouse (Alexa Fluor 647) (Invitrogen) at room temperature for 1h. Samples were analyzed on a Zeiss LSM-510 confocal microscope. HuH7 cells (4 x 10 5 cells) were transiently transfected with SKI-1-V5, rSt-1, rSt-2, ΔCT, rBTMD (15) and rCT constructs. Twenty four hours post-transfection, the permeabilized cells were treated and analyzed as above.
Immunocytochemistry of SKI-1 at the cell surface -For cell surface labeling, we used non-permeabilizing conditions (23) . HuH7 cells transiently transfected with 4 µg of SKI-1 cDNA, and 24h later the cells were labeled with the fluorescent CT-B conjugate as recommended (Vybrant Lipid Raft Labeling Kit, Molecular Probes). The cells were then washed 3 times with 1 X phosphate-buffered saline fixed with 4% paraformaldehyde for 1 h at 4°C. After fixation the cells were washed again and incubated overnight with 1:500 of Ab:N (15), and then incubated with a secondary fluorescently labeled Alexa Fluor 555 conjugated goat anti-rabbit IgG (Invitrogen) for 1h at room temperature.
Effects of rSt-1 and rSt-2 on the processing of ATF6 and tunicamycin on the generation of St-2 -4 x 10
3 CHOK1 cells were, co-transfected with 1 μg of rATF6 and empty 3 μg pIRES2 vector (control), or with either 3 μg of cDNAs coding for SKI-1, rSt-1, its mutant I989L or rSt-2. In another experiment we used triple transfections of 1 μg each of rATF6 and SKI-1, along with either an empty 2 μg pIRES2 vector (control), or with either 2 μg of cDNAs coding for rSt-1 or rSt-2. Twenty four hours later cells were treated or not with 2 μg/ml tunicamycin for 12h. Thereafter, the cells were treated with Nacetyl-leucinal-leucinal norleucinal (ALLN; Sigma) at a final concentration of 25 µg/ml for 1h.. The lysates were resolved on 6% SDS/PAGE and analyzed by Western blot using either a 1:5000 dilution of anti-FLAG M2 monoclonal antibody (Stratagene), as reported (6;24) or mAb:V5 at a 1:5000 dilution.
RESULTS

Analysis of the C-terminal Products of SKI-1 -Following transient transfection in
three cell lines of C-terminally V5-tagged full length SKI-1 (SKI-1), we analyzed the processing of the membrane-bound zymogen proSKI-1. HEK293 cells were pulse labeled with [ 3 H]Arg for 4h, the cell lysates immunoprecipitated with mAb-V5 and the products analyzed by SDS/PAGE in Tris-Tricine. The reported membranebound active ~106 kDa SKI-1 (Fig. 1A) autocatalytically sheds itself to produce a soluble secreted ~98 kDa sSKI-1 (15), leaving behind a membrane-bound ~13 kDa stump (St-1) (Fig. 1B) , as reported (15) . However, in this more resolving separation we also observed a smaller ~8.5 kDa V5-positive product running at the bottom of the gel, estimated at 11-17% of total (St-2; Fig. 1B ), suggesting that it represents a shorter C-terminal fragment. To further probe the possible cell-type dependence of the generation of St-2, we analyzed the SKI-1 products in two other cell lines, namely SRD-12B (lacking SKI-1 expression) (18) and CHOK1. These cells were transiently transfected with cDNAs coding for wild type (WT) SKI-1, its active site mutant (H249A) and its shedding site mutants (L952A, KLL/A and K948A) (15) . Cell lysates were analyzed by Western blotting using a mAb-V5, revealing the presence of both St-1 and/or St-2 in all cells (Fig. 1B) . In addition, while the autocatalytic generation of St-1 is abrogated in cells expressing the inactive enzyme SKI-1-H249A and in the triple shedding site mutant KLL/A (15), we observed that in all cases the St-2 fragment was generated at level of ~15%. Furthermore, unlike the autocatalytic shedding event leading to the production of St-1, the generation of St-2 is a SKI-1-activity independent process. This is based on the presence of this fragment in both SRD-12B cells and in the three cell lines expressing the inactive SKI-1-H249A (Fig.  1B) . Based on our calculations we can now state that in CHO-K1 cells St-2 is ~2-fold better generated from the rSt-1 than from full length SKI-1 or its H249A mutant (Figs. 2A,B). The estimated % generation of St-2 from FL-SKI-1 and its H249A mutant are comparable in CHO-K1 cells and somewhat lower in HEK293 cells. Since these values are representative of at least 5 experiments, we trust that this phenomenon is cell-type dependent. We note that the ratio of St-1 to St-2 is much higher in HEK293 cells than in CHO-K1 cells. The reason behind this is not clear. The results also demonstrated that shedding into St-1 is not a pre-requisite for the generation of St-2, since its production was observed in all shed site mutants that result in reduced (L952A and K948A) or absence (KLL/A) of St-1, as well as in SKI-1-H249A (Fig. 1B) .
Inhibition of St-2 Production -In order to identify whether the generation of St-2 is protease-dependent, we overexpressed WT SKI-1 ( Fig. 2A) or a secretable form of St-1 containing a signal peptide followed by a Flag tag at the N-terminus and a V5 tag at the C-terminus (rSt-1; Figs. 1A, 2B) in CHOK1 cells. Two days post-transfection, we incubated the cells expressing SKI-1 ( Fig. 2A) with either various protease inhibitors targeting different classes of enzymes (Table II) (21), or the general serine protease inhibitor AEBSF (21), or brefeldin A (BFA), a fungal metabolite that leads to the dissociation and fusion of most of the Golgi apparatus with the endoplasmic reticulum (ER) (25) . In addition, we expressed either WT or SKI-1-H249A in M19 cells lacking the expression of site-2 protease S2P (17) . We also co-expressed rSt-1 with general protease inhibitors, namely protease nexin-1 PN1 (26), Spn4.1A WT and its RRLL derivative Spn4.1A-RRLL (27), α1-antitrypsin (α1-AT), α1-antichymotrypsin (α1-AACT) and the furin/PC5 inhibitor α1-PDX (19;28) in CHOK1 and Neuro-2a cells (Fig. 2B) . Cell lysates were analyzed by Western blot using mAb-V5. While all inhibitors did not affect the production of St-2, we confirmed the earlier observation that AEBSF inhibits SKI-1 (21) , and hence the autocatalytic generation of St-1 ( Fig.  2A, cross) . In Fig. 2A , we note that ALLN, a proteasome and an inhibitor of Ca 2+ -dependent lysosomal cysteine proteases (29) , increases mostly the level of St-1, but not really St-2 (30% compared to 25% for WT). Since we later show that St-1 and St-2 as well as SKI-1 sort to endosomes/lysosomes it is possible that St-1 is degraded by lysosomal proteases, including Cys-proteases, and the latter are inhibited by ALLN, which is not as specific a proteasome inhibitor as lactacystine. Similarly, EDTA seems to decrease the production of St-1, possibly by its ability to bind calcium, which would reduce the activity of SKI-1 (4;15). In view of its ~8.5 kDa size and likely membrane attachment, it was possible that the signal peptidase may be the cognate converting enzyme. However, incubation with the signal peptidase inhibitor (Z-LL) 2 chloromethylketone (30) had no effect on St-2 production ( Fig. 2A, right panel) . However, we noticed that only BFA treatment resulted in a major reduction or complete inhibition of the production of St-2 from either its inactive H249A mutant ( Fig. 2A, star) or resulting from expression of rSt-1 (Fig. 2B, star) . Altogether the available data suggest that St-2 production can occur in the ER and is abrogated by BFA treatment. Since BFA was never reported to be a protease inhibitor, but could inhibit protein synthesis in cultured cells (31), we were faced with the possibility that BFA may either bring in from the Golgi an inhibitor or that St-2 may not be generated by proteolysis, but rather may be the result of an alternate mechanism that is inhibited by BFA. However, since the only known Golgi resident protease inhibitor PN1 (26) does not affect St-2 production (Fig. 2B) , this suggests that the later hypothesis is more likely.
N-terminal
Sequencing and Mass spectrometric Analysis of St-2 -As the level of St-2 obtained from full length SKI-1 is rather low (Fig. 1B) , and in order to isolate enough protein for microsequencing, HEK293 cells were transiently transfected with the Cterminally V5-tagged rSt-1 (Fig. 1A) Fig. 3A) . To determine the molecular mass of St-2, we generated enough of this protein from 5 x 10 7 transiently transfected HEK293 and CHOK1 cells with cDNAs of SKI-1 or rSt-1, and analyzed by time-of-flight mass spectrometry the molecular masses of immunoprecipitated products (Fig. 3B) (Fig.  3A) , or results from alternative translation starting at Met 990 .
Identification of Met 990 as a critical amino acid by mutagenesis and in vitro
transcription/translation studies -To define the important amino acids involved in the generation of St-2, different mutant constructs of rSt-1 were obtained using site directed mutagenesis (Fig. 4A) : I985A, I989L, M990L, M990A, M990I, Y994A, N995A, and the double mutant Y994A,N995A (Fig. 4A) . These rSt-1 constructs were expressed in CHOK1 cells and lysates analyzed by Western blot using mAb-V5 to detect the generation of St-2 (Fig. 4B) . Mutants of Met 990 to leucine, alanine and isoleucine failed to generate St-2 (Fig. 4B, stars) suggesting the critical importance of Met 990 for the generation of St-2.
In order to test whether Met 990 represents a start codon for an alternatively translated transcript, we mutagenized the nucleotide present at positions -3 from the ATG (ATCATG to CTCATG), which would create a less favorable Kozak sequence (34) and result in an I989L mutation. The data clearly show that the latter mutation resulted in >90% reduction in the generation of St-2 (Fig. 4B, star) , whereas all other mutants had no effect (Fig. 4B ). An independent confirmation of this observation was sought using the full length protein. Accordingly, analysis of the WT and mutated M990A SKI-1 revealed that in both HEK293 and CHOK1 cells, the M990A mutation completely blocked the generation of St-2 from SKI-1 (Fig. 4C) . The absolute requirement of methionine for St-2 generation strongly suggested that this product was a result of alternate translation starting at Met 990 . We therefore generated constructs in pcDNA3 vector of WT, M990A and I989L mutants of rSt-1 (Fig. 4A) . These constructs were transcribed and translated in vitro using TNT Quick Coupled Transcription/Translation systems using a wheat germ extract in the presence or absence of canine microsomes, as recommended by the manufacturer (Promega). Microsomes were added to enable efficient cleavage of the signal peptide, membrane insertion and translocation ensuring higher translation efficiency. The reaction products were separated on an 8% Tris-Tricine gel, and the proteins transferred to a nitrocellulose membrane and immunoblotted using mAb-V5 (Fig. 4D) . The data clearly show the presence of St-2 in the WT, which is reduced by >70% in the I989L mutant, and completely absent in the M990A mutant (Fig. 4D) . Thus, all available data support the conclusion that St-2 is produced by alternate translation. Since it lacks a signal peptide, rSt-2 is expected to have an opposite membrane orientation compared to SKI-1 or rSt-1. It was therefore of interest to define the subcellular localization of rSt-2 compared to either that of endogenous SKI-1 or its recombinant WT SKI-1 and rSt-1.
Generation and analysis of a specific Cterminal tail SKI-1 antibody -To study the subcellular localization of SKI-1-WT, rSt-1, rSt-2 and various recombinant constructs (Fig. 1A) , we synthesized the 17mer peptide (C) 1037 RPQLMQQVHPPKTPSV 1052 representing the 16aa of the C-terminus of hSKI-1 linked to an N-terminal cysteine residue, which was conjugated to the carrier protein Keyhole Limpet Hemocyanin (KLH). This peptide antigen was injected into two rabbits and the serum from each bleed was collected. The properties of the best resulting polyclonal antibody (Ab-CT # R2-02) were compared with those of mAb-V5 by Western blot and immunocytochemistry. Western blot analysis of transiently transfected human hepatocytes HuH7 and HepG2 cells with the WT cDNA, revealed that both antibodies recognize the A, B/B' and C forms of SKI-1 (Fig. 5A ). Confocal analysis of the subcellular localization of SKI-1 by immunocytochemistry (22) was performed 24h post transient transfection of HuH7 cells with WT SKI-1 cDNA and its inactive H249A mutant (Fig. 5B) . WT SKI-1 mostly concentrated in paranuclear structures reminiscent of the Golgi (arrows; Fig. 5B ), while the active site mutant H249A exhibits a diffused perinuclear staining indicating its presence in the ER (arrowheads, Fig. 5B ). Thus, Western blot and immunocytochemical analyses give similar results using either mAb-V5 or polyclonal Ab-CT.
Subcellular localization of endogenous SKI-1 and its recombinant constructs -
Western blot analysis of endogenous SKI-1 in HepG2 and/or HuH7 cells revealed similar A, B/B' and C-forms (Fig. 6A) . Subcellular localization studies in HuH7 cells (Fig. 6B ) revealed that SKI-1 colocalizes with markers of different subcellular compartments, i.e., Golga1 (a cis/medial Golgi marker), EEA1 (an early endosomal marker), and the cation independent mannose-6-phosphate receptor, CI-MPR, (a late endosomal marker) (22) . Although this agrees with the earlier report on the presence in CHOK1 cells of endogenous SKI-1/S1P in the cis/medial Golgi (35), our present data further revealed that endogenous SKI-1 can also traffic to endosomes/lysosomes. Upon overexpression of SKI-1 in either HEK293 cells (4) or HuH7 cells (Fig. 6C) , we observed similar punctate localizations reminiscent of endosomes/lysosomes (Fig.  6D) (4) . However, immunocytochemical analysis of overexpressed SKI-1 using Ab:N recognizing aa 634-651 (15) did not reveal the presence of this enzyme at the cell surface, as compared to the endogenous rafts CT-B component cell surface marker (Fig. 6E) . These data suggest that the endosomal/lysosomal localization of SKI-1 probably results from a direct transport from the Golgi to endosomes/lysosomes and not via cell surface internalization, as is the case for furin (36) .
We next analyzed the localization of overexpressed shorter forms of SKI-1 (Fig.  1A) , including rSt-1 (Figs. 6C, 7A ) and rSt-2 (Figs. 6C, 7B), r∆CT lacking the Cterminal cytosolic tail but still keeping the transmembrane domain (Fig. 7C) (15) , rBTMD, lacking both transmembrane domain and cytosolic tail (Fig. 7D) (15) , and the cytosolic tail construct with an added initiator methionine rCT (Fig. 7E) . Except for the rBTMD and rCT, localization studies show that all other constructs traffic to the same subcellular compartments as SKI-1 (Figs. 6D, 7) . rBTMD is not detectable intracellularly since it is rapidly secreted (15) . Interestingly, rCT that exhibits a putative basic nuclear localization signal (KRRK 1032 ) colocalized with the nuclear marker TOPO3, with a major accumulation within nucleoli (Fig. 7E) . The transmembrane domain is common to SKI-1, rSt-1, rSt-2 and r∆CT. It seems to be the dominant domain that determines the localization of these proteins to the Golgi, and subsequent subcellular compartments, i.e., endosomes/lysosomes, since its absence results in a secreted protein that does not accumulate inside the cell.
Overexpressed rSt-1 or rSt-2 impede ATF6
processing by SKI-1 -It is well known that treatment of cells with tunicamycin induces ER-stress resulting in increased processing of ATF6 by SKI-1/S1P followed by S2P into a nuclear form (10;21;24) . In an effort to define a functional role for either rSt-1 or rSt-2, we investigated the effect of either construct on the processing of ATF6 precursor (pATF6) into its nuclear form (nATF6) under stress conditions, such as tunicamycin treatment (10) . The data show that co-expression of either rSt-1, its I989L mutant or rSt-2 with ATF6 reduces its processing into the nuclear form by ~55%, 32% and 55%, respectively, whereas SKI-1 increases the level of the latter by ~1.7-fold (Fig. 8, left panel) . St-1 induced reduction of ATF6 processing is ~40% less by the I989L mutant that exhibits a reduced production of St-2. This suggests that St-2 is a better inhibitor of ATF6 processing than St-1. The data also show that co-expression of ATF6 together with SKI-1 and with either rSt-1 or rSt-2 respectively reduces ~60% and ~72% of the phenotype triggered by SKI-1 alone (Fig. 8, right panel) . In order to test whether stress conditions regulate the alternate translation of SKI-1 resulting in the production of St-2, we analyzed the effect of tunicamycin treatment on the generation of St-2. Accordingly, CHO-K1 cells transiently transfected with either FL-SKI-1, its H249A mutant (Fig. 9A) , rSt-2 rSt-1 or its M990A mutant (Fig. 9B) were tested in absence or presence of tunicamycin. Western blot analysis of the cell lysates revealed that stress induced by tunicamycin does not affect the % production of St-2 from either FL-SKI-1, its H249A mutant (Fig. 9A) , rSt-1 and rSt-2 (Fig.  9B) .
DISCUSSION
Since the discovery of the proprotein convertase SKI-1/S1P (4;18), it was realized that this convertase can process a number of membrane-bound proteins in the cis/medial Golgi, including transcription factors (2;3;11;24;37-39) and viral surface glycoproteins (6;12;14;40) . Biosynthetic analysis of the zymogen processing SKI-1 revealed an ordered autocatalytic activation process leading to the formation of intermediate B/B' forms in the ER and then an active C-form in the cis/medial Golgi (4;15;41;42). Indeed, it was soon found that most of the SKI-1 protein localizes in early Golgi compartments in both HEK293 cells (4) and in CHOK1 cells (35) . However, none of these data revealed whether SKI-1 can transiently be localized at other subcellular compartments, which may be implicated in its further processing via autocatalytic shedding into a soluble secreted form (15) . It was originally suggested, but not proven, that SKI-1 may be found in punctate structures reminiscent of endosomes/lysosomes and that its concentration could be increased upon neutralizing some lysosomal proteases (4) . In this study we investigated in more details the trafficking of SKI-1, its autocatalytic shedding into a secreted sSKI-1 and a membrane-bound stump St-1, and the generation of a novel membrane bound form called St-2, independent of SKI-1 activity and/or shedding (Fig. 1) .
In agreement with an earlier report (15), we confirmed that SKI-1 activity is needed for its shedding, since both the active site mutant H249A and the SKI-1 inhibitor AEBSF (21;43) prevented shedding (Figs.  1,2) . Biosynthetic radiolabeling analysis of either SKI-1 or BTMD-SKI-1-KDEL which remains in the ER (15) revealed that treatment with brefeldin A or expression of the SKI-1-KDEL construct prevented the production of the St-1 fragment (not shown). This suggests that shedding requires exit of SKI-1 from the ER and/or acidic conditions found in the cis/medial Golgi. In contrast to the membrane-bound convertases PC7 (44), PC5B (45;46) and Furin (36) which cycle from the cell surface to endosomes, SKI-1 does not seem to localize to the cell surface (Fig.  6E ) and hence may directly sort to endosomes/lysosomes (Fig. 6 ) from the trans-Golgi network (TGN). This is in agreement with our observation that shedding is not affected by inhibitors of metalloproteases (Fig. 2, Table II) , which usually process membrane-bound proteins at the cell surface (16;47;48) . We deduce that SKI-1 autocatalytic shedding may well occur in the Golgi where most of the active SKI-1 resides (Fig. 6) and not at the cell surface where the sheddases are usually localized.
Microsequencing and mass spectrometric analyses demonstrated that St-2 starts at Met 990 and consists of the segment comprising amino acids 990-1052 (Fig. 3) . Since the production of St-2 is inhibited by BFA treatment (Fig. 2) that can prevent mRNA translation (31) , and is abrogated when Met 990 is replaced by other amino acids in either the full length protein or in the rSt-1 construct (Fig. 4) , we suspected that St-2 may be produced by an alternate translation of the primary transcript at Met 990 . In vitro transcription/translation analyses of rSt-1 and its mutants M990A and I989L (Fig.  4D ) confirmed that production of St-2 utilizes an internal translation start site at Met 990 . Although viruses commonly make use of this mechanism to express variant proteins, alternate translation of secretory proteins is rather rare (49) . Initiation at Met 990 could either be attributed to internal entry of the ribosomal complex, instead of its attachment to the 5'cap, or to leaky ribosomal scanning due to less favorable nucleotide sequence surrounding the initiator methionine. Based on the Kozak's rules (34;50;51) the consensus sequence around the initiator methionine is GCC GCC (A/G)CC ATG (G/A) [the underlined residues are the most critical]. We note that the human SKI-1 nucleotide sequence surrounding Met 1 is CTT GTG ACC ATG A, while that around Met 990 is GGT GGG ATC ATG C. This shows that while both sequences exhibit optimal nucleotides at -3 and -6 positions, the first one has additionally an optimal +4 nucleotide , whereas the second one a -9 nucleotide. The efficiency of translation is clearly in favor of Met 1 (Fig. 1) befitting the predictions of the scanning hypothesis (34;50;51) . Interestingly, the ATG coding for M 990 is conserved in most vertebrates known to express SKI-1 from Danio rerio, to Xenopus tropicalis, to Homo sapiens. Since it is found in the last exon XXIV, which is 5 nucleotides away from the 3' acceptor splice site (52) , this may suggest that the C-terminal segment encoded by exon XXIV may have a specific function.
Interestingly, while the membrane orientation of St-2 is expected to be reversed from that of SKI-1 or St-1, they all share the same transmembrane domain, which seems to be critical for their subcellular localization to the Golgi and endosomes/lysosomes (Figs. 6, 7) . A similar critical importance of the transmembrane domain for subcellular localization in the Golgi and possibly endosomes has been reported for the β-secretases BACE1 (53) and BACE2 (54) . Intriguingly, we observed that expression of the highly basic cytosolic tail of SKI-1, lacking acidic residues (4), localizes the polypeptide to nucleoli (Fig. 7E) , a subnuclear structure involved in ribosomal RNA gene transcription. Mutation of the stretch KRRK 1032 to KAAK 1032 , or the putative phosphorylation sites S1026A, S1052A and T12049A did not change such nucleolar localization (not shown). However, addition of a V5 tag at the Cterminus of the cytosolic tail prevented its nuclear localization (not shown), suggesting that the nuclear localization determinants may reside at the C-terminus of this sequence.
Finally, in an effort to define a possible functional role for the observed stumps St-1 and St-2, we checked whether the SKI-1 generated processing of the ER-stress response factor ATF6 was affected by the overexpression of either constructs. A representative figure of our three independent experiments shows that both rSt-1 and rSt-2 diminish the processing of pATF6 into nATF6 by an as yet undefined mechanism (Fig. 8, left panel) . Furthermore, we also show that the coexpression of SKI-1 with either rSt-1 or rSt-2 reduces the phenotype triggered by SKI-1 alone (Fig. 8, right panel) . Finally, tunicamycin induced stress does not seem to increase the level of production of St-1 (Fig. 9) , suggesting that the observed phenomenon of alternate translation is not regulated by cellular stress. It is a matter of speculation whether the membrane-bound stumps St-1 and St-2 may interfere with the ER-stress machinery either in the ER or cis/medial Golgi. Alternatively, the rSt-1 and rSt-2 may act as dominant negatives of SKI-1.
In conclusion, the major SKI-1 activity is expected to be mostly in the cis/medial Golgi and may also be found in endosomes. However, while many candidate membrane-bound transcription factor substrates of SKI-1 are known (2;3;11;24;37-39), the putative endosomal substrates are yet to be identified. Alternatively, the presence of SKI-1 in endosomes/lysosomes may reflect its normal metabolic fate, as was reported for BACE1 (20) . It will be interesting to define the determinants of the transmembrane domain that are critical for the subcellular localization of SKI-1 and to possibly separate those required for Golgi localization from the ones needed for endosomal trafficking. Finally, the detailed mechanism behind the possible function of the St-1 and St-2 proteins on ATF6 processing is yet to be unraveled.
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The abbreviations used are: aa, amino acid; PC, proprotein convertase; SKI-1, subtilisin kexin isozyme-1; S1P, site-1-protease; ER, endoplasmic reticulum; St-1, stump-1; St-2, stump-2; CTF, C-terminal fragment; BTMD, before transmembrane domain; CT, cytosolic tail; WT, wild type; SREBP, sterol regulatory element-binding protein; ATF6, activating transcription factor 6; α 1 -AT, α 1 -antitryspin; α 1 -PDX, α 1 -antitrypsin Portland; α 1 -AACT, α 1 -antichymotrypsin; CHO, Chinese hamster ovary; HuH7, Human hepatocytes; DMEM, Dulbecco's modified Eagle's medium; Ab:N,anti-SKI-1 N terminus antibody; Ab:CT anti-SKI-1 C-terminal antibody; PBS, phosphate-buffered saline; PCR, polymerase chain reaction. The cells were fixed, permeabilized and analyzed for expression of SKI-1 using (Ab:CT or Ab:N in red), along with various markers (blue) such as the Golgi marker, Golga1, early endosomal marker, EEA1, late endosomal marker, CI-MPR, or nuclear marker, TOPO3. The presence of pink coloring in merged figures demonstrates co-localization of SKI-1 or its fragments with appropriate markers of different compartments. Bar =10µm. Fig. 8 . Effect of rSt-1 and rSt-2 on ATF6 processing. Western blot analysis of ATF6 using anti-FLAG antibody of CHOK1 cells transiently either co-transfected with cDNAs coding for ATF6 and either empty vector (pIRES) or SKI-1, rSt-1 , its mutant I989L, or rSt-2 (right panel), or triply transfected with cDNAs coding for ATF6, SKI-1 and either control pIRES, rSt-1, or rSt-2. Twenty four hours later cells were treated with 2 μg/ml tunicamycin for 12h. Thereafter the cells were treated with 25 μg/ml ALLN for 1h. The lysates were resolved on 6% SDS-PAGE. The migration positions of the ATF6 precursor (pATF6, ~90 kDa) and its nuclear form (nATF6, ~50 kDa), as well as the % cleavages of pATF6 into nATF6 are indicated. These values are representative of similar independent experiments repeated 3 times. Fig. 9 . Effect of tunicamycin induced stress on the generation of St-2. Western blot analysis using mAb:V5 of CHOK1 cells incubated in presence or absence of 2 μg/ml tunicamycin (Tm) and transiently transfected with cDNAs coding for [A] FL-SKI-1, its active site mutant H249A and [B] rSt-2, rSt-1, or its mutant M990A. The samples were analyzed as in Fig. 2 . The % generation of St-2 is indicated at the bottom of each gel. These values are representative of similar independent experiments repeated 3 times. 
